ADAR1 Capital Management »

Beyond Air shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Beyond Air (XAIR) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Beyond Air

Tip: Access up to 7 years of quarterly data

All positions including Beyond Air held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beyond Air by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.1M 1.2M 1.74

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Beyond Air

AIGH Capital Management
Soros Fund Management
Kingdon Capital Management
Vanguard Group
Bleichroeder
BlackRock
BlackRock
Geode Capital Management
Wealth Effects
Goldman Sachs Group
State Street Corporation
Morgan Stanley
Northern Trust
Advisor Group Holdings
Citadel Advisors

View all funds holding Beyond Air